ARIXTRA
Google image searchProduct monograph
Active ingredient
fondaparinux sodium, 2.5 MG/0.5 ML
DIN: 02245531
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS
Description: 0.5ML SINGLE USE PRE-FILLED SYRINGE
Schedule: Prescription
Company: ASPEN PHARMACARE CANADA INC.
Date: 10-JUL-2018
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AX — Other antithrombotic agents (ATC, ATC/DDD)
- B01AX05 — FONDAPARINUX (ATC/DDD)
Reference brand drug: Arixtra
